nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Infarction—Sorafenib—thyroid cancer	0.0436	0.0441	CcSEcCtD
Atenolol—Cardiogenic shock—Epirubicin—thyroid cancer	0.0213	0.0216	CcSEcCtD
Atenolol—Cardiogenic shock—Doxorubicin—thyroid cancer	0.0197	0.02	CcSEcCtD
Atenolol—Alopecia reversible—Epirubicin—thyroid cancer	0.0197	0.0199	CcSEcCtD
Atenolol—Respiratory distress—Sorafenib—thyroid cancer	0.0191	0.0193	CcSEcCtD
Atenolol—Alopecia reversible—Doxorubicin—thyroid cancer	0.0182	0.0184	CcSEcCtD
Atenolol—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.0166	0.0168	CcSEcCtD
Atenolol—Dry eye—Vandetanib—thyroid cancer	0.0166	0.0168	CcSEcCtD
Atenolol—Atrial fibrillation—Vandetanib—thyroid cancer	0.0137	0.0139	CcSEcCtD
Atenolol—Cardiac failure—Vandetanib—thyroid cancer	0.0133	0.0135	CcSEcCtD
Atenolol—Lethargy—Vandetanib—thyroid cancer	0.0133	0.0135	CcSEcCtD
Atenolol—Cardiac arrest—Vandetanib—thyroid cancer	0.0124	0.0125	CcSEcCtD
Atenolol—Cardiomegaly—Epirubicin—thyroid cancer	0.0123	0.0124	CcSEcCtD
Atenolol—Cardiomegaly—Doxorubicin—thyroid cancer	0.0113	0.0115	CcSEcCtD
Atenolol—Bronchospasm—Vandetanib—thyroid cancer	0.0111	0.0112	CcSEcCtD
Atenolol—Depression—Vandetanib—thyroid cancer	0.01	0.0101	CcSEcCtD
Atenolol—Renal failure—Vandetanib—thyroid cancer	0.00987	0.00998	CcSEcCtD
Atenolol—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00969	0.0098	CcSEcCtD
Atenolol—Epistaxis—Vandetanib—thyroid cancer	0.00947	0.00958	CcSEcCtD
Atenolol—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00931	0.00942	CcSEcCtD
Atenolol—Bradycardia—Vandetanib—thyroid cancer	0.00917	0.00928	CcSEcCtD
Atenolol—Cardiac failure—Sorafenib—thyroid cancer	0.009	0.00911	CcSEcCtD
Atenolol—Pain in extremity—Sorafenib—thyroid cancer	0.00879	0.00889	CcSEcCtD
Atenolol—Visual impairment—Vandetanib—thyroid cancer	0.00868	0.00879	CcSEcCtD
Atenolol—Mood swings—Sorafenib—thyroid cancer	0.00832	0.00842	CcSEcCtD
Atenolol—Arrhythmia—Vandetanib—thyroid cancer	0.00805	0.00815	CcSEcCtD
Atenolol—Alopecia—Vandetanib—thyroid cancer	0.00796	0.00806	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00791	0.00801	CcSEcCtD
Atenolol—Vision blurred—Vandetanib—thyroid cancer	0.00739	0.00748	CcSEcCtD
Atenolol—Abdominal discomfort—Sorafenib—thyroid cancer	0.00728	0.00737	CcSEcCtD
Atenolol—Psoriasis—Epirubicin—thyroid cancer	0.00712	0.0072	CcSEcCtD
Atenolol—Erectile dysfunction—Sorafenib—thyroid cancer	0.00699	0.00708	CcSEcCtD
Atenolol—Loss of consciousness—Vandetanib—thyroid cancer	0.00689	0.00698	CcSEcCtD
Atenolol—Cough—Vandetanib—thyroid cancer	0.00684	0.00693	CcSEcCtD
Atenolol—Chest pain—Vandetanib—thyroid cancer	0.00668	0.00676	CcSEcCtD
Atenolol—Renal failure—Sorafenib—thyroid cancer	0.00666	0.00674	CcSEcCtD
Atenolol—Anxiety—Vandetanib—thyroid cancer	0.00665	0.00673	CcSEcCtD
Atenolol—Myocardial infarction—Sorafenib—thyroid cancer	0.00664	0.00672	CcSEcCtD
Atenolol—Psoriasis—Doxorubicin—thyroid cancer	0.00658	0.00666	CcSEcCtD
Atenolol—Dry mouth—Vandetanib—thyroid cancer	0.00653	0.00661	CcSEcCtD
Atenolol—Oedema—Vandetanib—thyroid cancer	0.0064	0.00648	CcSEcCtD
Atenolol—Epistaxis—Sorafenib—thyroid cancer	0.00639	0.00646	CcSEcCtD
Atenolol—Thrombocytopenia—Vandetanib—thyroid cancer	0.00627	0.00634	CcSEcCtD
Atenolol—Rash erythematous—Epirubicin—thyroid cancer	0.00584	0.00591	CcSEcCtD
Atenolol—Insomnia—Vandetanib—thyroid cancer	0.00579	0.00586	CcSEcCtD
Atenolol—Paraesthesia—Vandetanib—thyroid cancer	0.00575	0.00582	CcSEcCtD
Atenolol—Dyspnoea—Vandetanib—thyroid cancer	0.00571	0.00578	CcSEcCtD
Atenolol—Tinnitus—Sorafenib—thyroid cancer	0.00567	0.00573	CcSEcCtD
Atenolol—Flushing—Sorafenib—thyroid cancer	0.00564	0.00571	CcSEcCtD
Atenolol—Dyspepsia—Vandetanib—thyroid cancer	0.00563	0.0057	CcSEcCtD
Atenolol—Decreased appetite—Vandetanib—thyroid cancer	0.00556	0.00563	CcSEcCtD
Atenolol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00553	0.00559	CcSEcCtD
Atenolol—Fatigue—Vandetanib—thyroid cancer	0.00552	0.00559	CcSEcCtD
Atenolol—Pain—Vandetanib—thyroid cancer	0.00547	0.00554	CcSEcCtD
Atenolol—Constipation—Vandetanib—thyroid cancer	0.00547	0.00554	CcSEcCtD
Atenolol—Arrhythmia—Sorafenib—thyroid cancer	0.00543	0.00549	CcSEcCtD
Atenolol—Rash erythematous—Doxorubicin—thyroid cancer	0.0054	0.00547	CcSEcCtD
Atenolol—Alopecia—Sorafenib—thyroid cancer	0.00537	0.00544	CcSEcCtD
Atenolol—Body temperature increased—Vandetanib—thyroid cancer	0.00506	0.00512	CcSEcCtD
Atenolol—Ibuprofen—PPARG—thyroid cancer	0.00501	0.422	CrCbGaD
Atenolol—Syncope—Sorafenib—thyroid cancer	0.00474	0.0048	CcSEcCtD
Atenolol—Chlorphenesin—PTGS2—thyroid cancer	0.00474	0.399	CrCbGaD
Atenolol—Loss of consciousness—Sorafenib—thyroid cancer	0.00465	0.00471	CcSEcCtD
Atenolol—Cough—Sorafenib—thyroid cancer	0.00462	0.00467	CcSEcCtD
Atenolol—Atrioventricular block—Epirubicin—thyroid cancer	0.00461	0.00467	CcSEcCtD
Atenolol—Asthenia—Vandetanib—thyroid cancer	0.00459	0.00465	CcSEcCtD
Atenolol—Pruritus—Vandetanib—thyroid cancer	0.00453	0.00458	CcSEcCtD
Atenolol—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00447	0.00453	CcSEcCtD
Atenolol—Abnormal dreams—Epirubicin—thyroid cancer	0.00442	0.00447	CcSEcCtD
Atenolol—Dry mouth—Sorafenib—thyroid cancer	0.00441	0.00446	CcSEcCtD
Atenolol—Diarrhoea—Vandetanib—thyroid cancer	0.00438	0.00443	CcSEcCtD
Atenolol—Atrioventricular block—Doxorubicin—thyroid cancer	0.00427	0.00432	CcSEcCtD
Atenolol—Shock—Sorafenib—thyroid cancer	0.00425	0.0043	CcSEcCtD
Atenolol—Dizziness—Vandetanib—thyroid cancer	0.00423	0.00428	CcSEcCtD
Atenolol—Thrombocytopenia—Sorafenib—thyroid cancer	0.00423	0.00428	CcSEcCtD
Atenolol—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00414	0.00419	CcSEcCtD
Atenolol—Dry eye—Epirubicin—thyroid cancer	0.00413	0.00418	CcSEcCtD
Atenolol—Anorexia—Sorafenib—thyroid cancer	0.00412	0.00417	CcSEcCtD
Atenolol—Abnormal dreams—Doxorubicin—thyroid cancer	0.00409	0.00414	CcSEcCtD
Atenolol—Rash—Vandetanib—thyroid cancer	0.00404	0.00408	CcSEcCtD
Atenolol—Dermatitis—Vandetanib—thyroid cancer	0.00403	0.00408	CcSEcCtD
Atenolol—Headache—Vandetanib—thyroid cancer	0.00401	0.00406	CcSEcCtD
Atenolol—Pulmonary oedema—Epirubicin—thyroid cancer	0.00398	0.00403	CcSEcCtD
Atenolol—Dyspnoea—Sorafenib—thyroid cancer	0.00385	0.0039	CcSEcCtD
Atenolol—Dry eye—Doxorubicin—thyroid cancer	0.00382	0.00387	CcSEcCtD
Atenolol—Nausea—Vandetanib—thyroid cancer	0.0038	0.00385	CcSEcCtD
Atenolol—Dyspepsia—Sorafenib—thyroid cancer	0.0038	0.00385	CcSEcCtD
Atenolol—Decreased appetite—Sorafenib—thyroid cancer	0.00375	0.0038	CcSEcCtD
Atenolol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00373	0.00377	CcSEcCtD
Atenolol—Fatigue—Sorafenib—thyroid cancer	0.00372	0.00377	CcSEcCtD
Atenolol—Pain—Sorafenib—thyroid cancer	0.00369	0.00374	CcSEcCtD
Atenolol—Constipation—Sorafenib—thyroid cancer	0.00369	0.00374	CcSEcCtD
Atenolol—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00368	0.00373	CcSEcCtD
Atenolol—Vascular purpura—Epirubicin—thyroid cancer	0.00363	0.00367	CcSEcCtD
Atenolol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00358	0.00362	CcSEcCtD
Atenolol—Hot flush—Epirubicin—thyroid cancer	0.00347	0.00351	CcSEcCtD
Atenolol—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00344	0.00348	CcSEcCtD
Atenolol—Menopausal symptoms—Epirubicin—thyroid cancer	0.00344	0.00348	CcSEcCtD
Atenolol—Body temperature increased—Sorafenib—thyroid cancer	0.00341	0.00345	CcSEcCtD
Atenolol—Purpura—Epirubicin—thyroid cancer	0.00337	0.00341	CcSEcCtD
Atenolol—Vascular purpura—Doxorubicin—thyroid cancer	0.00336	0.0034	CcSEcCtD
Atenolol—Cardiac failure—Epirubicin—thyroid cancer	0.00333	0.00337	CcSEcCtD
Atenolol—Lethargy—Epirubicin—thyroid cancer	0.00331	0.00335	CcSEcCtD
Atenolol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00331	0.00335	CcSEcCtD
Atenolol—Pain in extremity—Epirubicin—thyroid cancer	0.00325	0.00329	CcSEcCtD
Atenolol—Hot flush—Doxorubicin—thyroid cancer	0.00321	0.00325	CcSEcCtD
Atenolol—Affect lability—Epirubicin—thyroid cancer	0.0032	0.00323	CcSEcCtD
Atenolol—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00318	0.00322	CcSEcCtD
Atenolol—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00318	0.00322	CcSEcCtD
Atenolol—Purpura—Doxorubicin—thyroid cancer	0.00312	0.00315	CcSEcCtD
Atenolol—Asthenia—Sorafenib—thyroid cancer	0.0031	0.00314	CcSEcCtD
Atenolol—Cardiac arrest—Epirubicin—thyroid cancer	0.00309	0.00312	CcSEcCtD
Atenolol—Cardiac failure—Doxorubicin—thyroid cancer	0.00308	0.00312	CcSEcCtD
Atenolol—Mood swings—Epirubicin—thyroid cancer	0.00308	0.00311	CcSEcCtD
Atenolol—Lethargy—Doxorubicin—thyroid cancer	0.00307	0.0031	CcSEcCtD
Atenolol—Pruritus—Sorafenib—thyroid cancer	0.00305	0.00309	CcSEcCtD
Atenolol—Ataxia—Epirubicin—thyroid cancer	0.00305	0.00309	CcSEcCtD
Atenolol—Pain in extremity—Doxorubicin—thyroid cancer	0.003	0.00304	CcSEcCtD
Atenolol—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00297	0.003	CcSEcCtD
Atenolol—Affect lability—Doxorubicin—thyroid cancer	0.00296	0.00299	CcSEcCtD
Atenolol—Diarrhoea—Sorafenib—thyroid cancer	0.00295	0.00299	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00292	0.00296	CcSEcCtD
Atenolol—Cardiac arrest—Doxorubicin—thyroid cancer	0.00286	0.00289	CcSEcCtD
Atenolol—Dizziness—Sorafenib—thyroid cancer	0.00286	0.00289	CcSEcCtD
Atenolol—Mood swings—Doxorubicin—thyroid cancer	0.00285	0.00288	CcSEcCtD
Atenolol—Ataxia—Doxorubicin—thyroid cancer	0.00282	0.00286	CcSEcCtD
Atenolol—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00274	0.00278	CcSEcCtD
Atenolol—Rash—Sorafenib—thyroid cancer	0.00272	0.00276	CcSEcCtD
Atenolol—Dermatitis—Sorafenib—thyroid cancer	0.00272	0.00275	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00271	0.00274	CcSEcCtD
Atenolol—Headache—Sorafenib—thyroid cancer	0.00271	0.00274	CcSEcCtD
Atenolol—Nausea—Sorafenib—thyroid cancer	0.00256	0.0026	CcSEcCtD
Atenolol—Drowsiness—Epirubicin—thyroid cancer	0.0025	0.00253	CcSEcCtD
Atenolol—Renal failure—Epirubicin—thyroid cancer	0.00246	0.00249	CcSEcCtD
Atenolol—Sweating—Epirubicin—thyroid cancer	0.0024	0.00243	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—thyroid cancer	0.00236	0.00239	CcSEcCtD
Atenolol—Agranulocytosis—Epirubicin—thyroid cancer	0.00233	0.00236	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—thyroid cancer	0.00232	0.00234	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—thyroid cancer	0.00229	0.00231	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—thyroid cancer	0.00228	0.0023	CcSEcCtD
Atenolol—Sweating—Doxorubicin—thyroid cancer	0.00222	0.00225	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—thyroid cancer	0.00218	0.00221	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—thyroid cancer	0.00216	0.00219	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—thyroid cancer	0.00216	0.00219	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—thyroid cancer	0.00212	0.178	CrCbGaD
Atenolol—Bradycardia—Doxorubicin—thyroid cancer	0.00212	0.00214	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—thyroid cancer	0.00209	0.00212	CcSEcCtD
Atenolol—Flushing—Epirubicin—thyroid cancer	0.00208	0.00211	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—thyroid cancer	0.00201	0.00203	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—thyroid cancer	0.002	0.00203	CcSEcCtD
Atenolol—Alopecia—Epirubicin—thyroid cancer	0.00198	0.00201	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—thyroid cancer	0.00194	0.00196	CcSEcCtD
Atenolol—Flushing—Doxorubicin—thyroid cancer	0.00193	0.00195	CcSEcCtD
Atenolol—Tension—Epirubicin—thyroid cancer	0.00192	0.00194	CcSEcCtD
Atenolol—Nervousness—Epirubicin—thyroid cancer	0.0019	0.00192	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—thyroid cancer	0.00186	0.00188	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—thyroid cancer	0.00184	0.00186	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—thyroid cancer	0.00184	0.00186	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—thyroid cancer	0.00181	0.00184	CcSEcCtD
Atenolol—Tension—Doxorubicin—thyroid cancer	0.00178	0.0018	CcSEcCtD
Atenolol—Malaise—Epirubicin—thyroid cancer	0.00176	0.00178	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—thyroid cancer	0.00176	0.00178	CcSEcCtD
Atenolol—Vertigo—Epirubicin—thyroid cancer	0.00176	0.00178	CcSEcCtD
Atenolol—Syncope—Epirubicin—thyroid cancer	0.00175	0.00177	CcSEcCtD
Atenolol—Palpitations—Epirubicin—thyroid cancer	0.00173	0.00175	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—thyroid cancer	0.00172	0.00174	CcSEcCtD
Atenolol—Cough—Epirubicin—thyroid cancer	0.00171	0.00173	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—thyroid cancer	0.00171	0.00173	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00168	0.0017	CcSEcCtD
Atenolol—Chest pain—Epirubicin—thyroid cancer	0.00166	0.00168	CcSEcCtD
Atenolol—Anxiety—Epirubicin—thyroid cancer	0.00166	0.00168	CcSEcCtD
Atenolol—Discomfort—Epirubicin—thyroid cancer	0.00164	0.00166	CcSEcCtD
Atenolol—Malaise—Doxorubicin—thyroid cancer	0.00163	0.00165	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—thyroid cancer	0.00163	0.00165	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—thyroid cancer	0.00163	0.00164	CcSEcCtD
Atenolol—Syncope—Doxorubicin—thyroid cancer	0.00162	0.00164	CcSEcCtD
Atenolol—Confusional state—Epirubicin—thyroid cancer	0.00161	0.00163	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—thyroid cancer	0.0016	0.00162	CcSEcCtD
Atenolol—Oedema—Epirubicin—thyroid cancer	0.0016	0.00161	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—thyroid cancer	0.00159	0.00161	CcSEcCtD
Atenolol—Cough—Doxorubicin—thyroid cancer	0.00158	0.0016	CcSEcCtD
Atenolol—Shock—Epirubicin—thyroid cancer	0.00157	0.00159	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—thyroid cancer	0.00156	0.00158	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—thyroid cancer	0.00156	0.00158	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—thyroid cancer	0.00154	0.00156	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—thyroid cancer	0.00154	0.00156	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—thyroid cancer	0.00153	0.00155	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—thyroid cancer	0.00152	0.00154	CcSEcCtD
Atenolol—Anorexia—Epirubicin—thyroid cancer	0.00152	0.00154	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—thyroid cancer	0.00151	0.00152	CcSEcCtD
Atenolol—Hypotension—Epirubicin—thyroid cancer	0.00149	0.00151	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—thyroid cancer	0.00149	0.00151	CcSEcCtD
Atenolol—Oedema—Doxorubicin—thyroid cancer	0.00148	0.00149	CcSEcCtD
Atenolol—Shock—Doxorubicin—thyroid cancer	0.00145	0.00147	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00145	0.00146	CcSEcCtD
Atenolol—Insomnia—Epirubicin—thyroid cancer	0.00144	0.00146	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—thyroid cancer	0.00144	0.00146	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—thyroid cancer	0.00143	0.00145	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00143	0.00144	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—thyroid cancer	0.00142	0.00144	CcSEcCtD
Atenolol—Somnolence—Epirubicin—thyroid cancer	0.00142	0.00144	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—thyroid cancer	0.00141	0.00142	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—thyroid cancer	0.0014	0.00142	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—thyroid cancer	0.00139	0.0014	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—thyroid cancer	0.00138	0.0014	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00138	0.00139	CcSEcCtD
Atenolol—Fatigue—Epirubicin—thyroid cancer	0.00138	0.00139	CcSEcCtD
Atenolol—Pain—Epirubicin—thyroid cancer	0.00136	0.00138	CcSEcCtD
Atenolol—Constipation—Epirubicin—thyroid cancer	0.00136	0.00138	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—thyroid cancer	0.00134	0.00135	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—thyroid cancer	0.00133	0.00134	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—thyroid cancer	0.00132	0.00133	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—thyroid cancer	0.00132	0.00133	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—thyroid cancer	0.00131	0.00133	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—thyroid cancer	0.0013	0.00132	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—thyroid cancer	0.00128	0.0013	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00127	0.00129	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—thyroid cancer	0.00127	0.00129	CcSEcCtD
Atenolol—Constipation—Doxorubicin—thyroid cancer	0.00126	0.00128	CcSEcCtD
Atenolol—Pain—Doxorubicin—thyroid cancer	0.00126	0.00128	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—thyroid cancer	0.00126	0.00128	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—thyroid cancer	0.00122	0.00123	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—thyroid cancer	0.00117	0.00118	CcSEcCtD
Atenolol—Asthenia—Epirubicin—thyroid cancer	0.00114	0.00116	CcSEcCtD
Atenolol—Pruritus—Epirubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—thyroid cancer	0.00109	0.0011	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—thyroid cancer	0.00106	0.00107	CcSEcCtD
Atenolol—Dizziness—Epirubicin—thyroid cancer	0.00106	0.00107	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—thyroid cancer	0.00104	0.00106	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—thyroid cancer	0.00101	0.00102	CcSEcCtD
Atenolol—Rash—Epirubicin—thyroid cancer	0.00101	0.00102	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—thyroid cancer	0.00101	0.00102	CcSEcCtD
Atenolol—Headache—Epirubicin—thyroid cancer	0.001	0.00101	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—thyroid cancer	0.000976	0.000988	CcSEcCtD
Atenolol—Nausea—Epirubicin—thyroid cancer	0.000948	0.000959	CcSEcCtD
Atenolol—Rash—Doxorubicin—thyroid cancer	0.000931	0.000942	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—thyroid cancer	0.00093	0.000941	CcSEcCtD
Atenolol—Headache—Doxorubicin—thyroid cancer	0.000925	0.000936	CcSEcCtD
Atenolol—Nausea—Doxorubicin—thyroid cancer	0.000877	0.000888	CcSEcCtD
